Skip to content

Mobile Geriatric Unit (MGU) to Reduce Hospitalisations in Nursing Home Residents

Mobile Geriatric Unit (MGU) to Reduce Hospitalisations in Nursing Home Residents: A Prospective Observational Before-After Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07634757
Acronym
MGU
Enrollment
4907
Registered
2026-06-09
Start date
2026-09-01
Completion date
2028-03-01
Last updated
2026-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospitalisation Prevention, Nursing Home Care

Keywords

Nursing home, Geriatrics, Telemedicine, Hospitalisation, Mobile diagnostics

Brief summary

This prospective observational before-after study evaluates the impact of a Mobile Geriatric Unit (MGU) on hospitalisation rates among nursing home residents. The study includes a 12-month control phase with usual care followed by a 12-month intervention phase during which the MGU is implemented. The MGU provides advanced on-site diagnostics and telemedicine-supported specialist consultation within nursing homes.

Detailed description

This prospective observational before-after study evaluates the impact of a Mobile Geriatric Unit (MGU) on hospitalisation rates among nursing home residents in Saarland, Germany. The study includes a 12-month control phase with usual care followed by a 12-month intervention phase with MGU implementation in 46 nursing homes. The MGU provides on-site advanced diagnostics (CT, X-ray, ultrasound, ECG, EEG, and laboratory testing) supported by telemedicine consultation with hospital specialists. A physician and radiology technician perform diagnostics in the nursing home, with results communicated to the general practitioner for treatment decisions within 48 hours. Usual care involves hospital referral and in-hospital diagnostics. The intervention aims to reduce avoidable hospital admissions by providing diagnostics and specialist input directly in the nursing home. The primary outcome is hospital admissions per person-year. Secondary outcomes include mortality, functional and cognitive status, quality of life (EQ-5D-5L), complications, healthcare costs, and 30-day hospitalisation-free survival. Eligible participants are nursing home residents with consent or proxy consent; those requiring immediate hospitalisation are excluded. Data are obtained from routine care and medical records, MGU documentation, structured assessments, and follow-up. Multilevel Poisson regression and interrupted time series analysis will be used. The study was approved by the Ethics Committee of Saarland (AZ 159-21) and conducted in accordance with the Declaration of Helsinki.

Interventions

OTHERMobile Geriatric Unit (MGU)

The MGU is a mobile diagnostic unit providing on-site diagnostics in nursing homes. It includes a 32-slice (64 slice reconstruction) whole body CT scanner, digital X-ray, portable ultrasound, ECG, EEG, and point-of-care laboratory diagnostics. A physician and radiology technician perform diagnostics on-site. Results are transmitted via telemedicine to hospital specialists and communicated to the general practitioner for treatment decisions within 48 hours.

Sponsors

Universität des Saarlandes
Lead SponsorOTHER
DIKOM Consortium
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Residents of participating nursing homes * Informed consent from participant or legal representative

Exclusion criteria

* Acute life-threatening conditions requiring immediate hospitalisation

Design outcomes

Primary

MeasureTime frameDescription
Hospital admissions per person-yearUp to 24 monthsNumber of inpatient hospital admissions, excluding elective admissions.

Secondary

MeasureTime frameDescription
MortalityDay 180Mortality
Functional status; mobility: modified Rankin Scale (mRS)Day 180Modified Rankin Scale (mRS): 0: No symptoms 1. No significant disability 2. Slight disability 3. Moderate disability 4. Moderately severe disability 5. Severe disability 6. Death Minimum value: 0 (best outcome) Maximum value: 6 (worst outcome)
Functional status; frailty: Clinical Frailty ScaleDay 180Clinical Frailty Scale (as according to Moorhouse and Rockwood\*): 1. very fit 2. well 3. managing well 4. apparently vulnerable 5. mildly frail 6. moderately frail 7. severely frail 8. very severely frail 9. terminally ill Minimum value: 1 (best outcome) Maximum value: 9 (worst outcome) \* Moorhouse P, Rockwood K. Frailty and its quantitative clinical evaluation. J R Coll Physicians Edinb 2012; 42: 333-40
Cognitive statusDay 180The cognitive performance assessment is carried out through subjective evaluation by the nursing home's nursing staff at day 180.
Quality of life (EQ-5D-5L)Day 180EQ-5D-5L is a standardised measure of health-related quality of life developed by the EuroQol Group and assesses health status in terms of five dimensions of health. The five levels in each dimension are worded as (1) 'not /no problems', (2) 'slight problems', (3) 'moderate problems', (4) 'severe problems' and (5) 'unable to' (mobility, self-care, usual activities), 'extreme' (pain/depression), or 'extremely' (anxiety/depression). Minimum value: 1 (best outcome) Maximum value: 5 (worst outcome)
Healthcare costsDay 360Hospitalisation, transport, and MGU costs
30-day hospitalisation-free survivalDay 30Hospitalisation-free survival at day 30

Countries

Germany

Contacts

CONTACTKlaus Fassbender, Professor
klaus.fassbender@uks.eu+49 681 302 75027
CONTACTSilke Walter
silke.walter@uni-saarland.de
PRINCIPAL_INVESTIGATORKlaus Fassbender, Professor

Universität des Saarlandes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 11, 2026